Sartorius logo

Sartorius

Stock
Stock
ISIN: DE0007165607
Ticker: SRT
DE0007165607
SRT

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Sartorius has so far distributed $0.791 in 2024. The next dividend will be paid on 04.04.2025


$0.476

CHART BY

Frequently asked questions

What is Sartorius's market capitalization?

The market capitalization of Sartorius is $12.70B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Sartorius's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Sartorius is 145.65. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Sartorius?

Sartorius's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.263. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Sartorius's stock?

Currently, 5 analysts cover Sartorius's stock, with a consensus target price of $252.76. Analyst ratings provide insights into the stock's expected performance.

What is Sartorius's revenue over the trailing twelve months?

Over the trailing twelve months, Sartorius reported a revenue of $3.47B.

What is the EBITDA for Sartorius?

Sartorius's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $909.41M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Sartorius?

Sartorius has a free cash flow of $292.67M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Sartorius have, and what sector and industry does it belong to?

Sartorius employs approximately 14,614 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.

What is the free float of Sartorius's shares?

The free float of Sartorius is 1.49M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$12.70B
EPS (TTM) 
$1.263
Free Float 
1.49M
P/E ratio (TTM) 
145.65
Revenue (TTM) 
$3.47B
EBITDA (TTM) 
$909.41M
Free Cashflow (TTM) 
$292.67M

Pricing

1D span
$177.72$185.11
52W span
$173.52$315.94

Analyst Ratings

The price target is $252.76 and the stock is covered by 5 analysts.

Buy

3

Hold

2

Sell

0

Information

Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.

Employees
14,614
Industries
Pharmaceuticals: Major
Sector
Health Care

Identifier

ISIN
DE0007165607
Primary Ticker
SRT

Knockouts

Join the conversation